NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-081-2019-0-PC-01 Method For Improving Insulin Sensitivity PCT PCT PCT/US2020/000009 Expired
NCI E-230-2012-0-US-58 T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 US DIV 16/812,845 Abandoned
NIDDK E-081-2019-0-EP-01 Method For Improving Insulin Sensitivity EP National Stage 20774479.8 Pending
NIDDK E-081-2019-0-KR-01 Method For Improving Insulin Sensitivity KR National Stage 10-2021-7033113 Pending
NIAID E-131-2020-0-US-01 Anti-Coronavirus Antibodies And Methods Of Use US 62/987,313 Abandoned
NIDDK E-081-2019-0-AU-01 Method of producing modified amyloid precursor protein anchored with detectable moieties and modified amyloid peptides derived thereof AU National Stage 2020239920 Pending
NCI E-207-2017-1-US-02 ADAM17 BINDING MOLECULES AND USES THEREOF US National Stage 17/437,065 Pending
NCI E-207-2017-1-EP-03 ADAM17 BINDING MOLECULES AND USES THEREOF EP National Stage 20769619.6 Pending
NCI E-207-2017-1-PCT-02 ADAM17 BINDING MOLECULES AND USES THEREOF PCT PCT PCT/US2020/021603 Expired
NHLBI E-085-2019-0-PCT-01 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE PCT PCT COMB PCT/US2020/021494 Expired
NIDDK E-043-2020-0-US-01 RNA Target Enrichment or Depletion of Biological Supplies US 62/986,055 Abandoned
NIAID E-052-2021-0-US-01 Engineered Influenza Neuraminidase Antigens US 62/986,295 Abandoned
NCI E-241-2016-0-US-06 Micro-Dose Calibrator US National Stage 16/644,441 11029418 Issued PDF
NIBIB E-076-2020-0-US-01 Fluorescence Scanning System For Analytical Ultracentrifugation US 62/985,222 Abandoned
NCI E-040-2012-0-KR-47 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2020-7006131 Issued
NIA E-013-2010-0-US-16 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US CON 16/806,659 10925840 Issued PDF
NCI E-205-2010-2-JP-19 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2020-35079 Pending
NCATS E-077-2020-2-US-01 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINES AS IRAK 1/4 AND FLT3 INHIBITORS US CIP 16/804,518 11542261 Issued PDF
NIA E-249-2016-0-HK-17 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM HK National Stage 62020003496.0 Pending
NCI E-088-2020-0-US-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 62/981,856 Abandoned
NHGRI E-180-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/981,564 Abandoned
NHGRI E-179-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING
IMMUNITY TO VIRAL TRANSFER VECTORS 		US 62/981,555 Abandoned
NHGRI E-149-2017-0-US-04 BIOMARKERS OF ORGANIC ACIDEMIAS US National Stage 16/641,994 11372004 Issued PDF
NCI E-137-2019-0-US-01 METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE US 62/981,382 Abandoned
NCI E-238-2015-0-HK-09 MOLECULAR NANOTAGS HK CN 62020003242.8 Issued
NIAID E-236-2018-0-US-03 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof US National Stage 16/641,580 Abandoned
NHLBI E-090-2020-0-US-01 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE US 62/980,854 Abandoned
NCI E-234-2014-1-AU-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF AU DIV 2020201292 Issued
NCATS E-168-2019-0-US-01 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS US 62/979,429 Abandoned
NCI E-143-2017-0-US-03 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range US National Stage 16/640,620 10994029 Issued PDF
NCATS E-050-2012-0-JP-14 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP DIV 2020-026808 Pending
NIAID E-020-2020-0-US-01 EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF US 62/979,070 Abandoned
NCI E-099-2014-0-EP-11 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF EP DIV 20158336.6 Issued
NIAID E-145-2011-0-AU-16 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2020201140 Issued
NEI E-057-2020-0-US-01 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION US 62/978,070 Abandoned
NHLBI E-175-2017-0-US-03 Hybrid CT System With Additional Detectors In Close Proximity To The Body US National Stage 16/639,469 1124-12-07 Issued PDF
CC E-001-2019-1-EP-03 Handgrip Relaxometer Devices EP National Stage 20710721.0 Pending
NCI E-074-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 62/976,655 Abandoned
CC E-001-2019-1-PCT-01 Handgrip Relaxometer Devices PCT PCT COMB PCT/US2020/018273 Expired
NCCIH E-081-2020-0-US-01 MARGARIC ACID DECREASES PIEZO2-MEDIATED PAIN US 62/976,014 Abandoned
NCI E-031-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US 62/975,544 Abandoned
NCI E-243-2015-0-US-05 ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US CON 16/788,895 Abandoned
NIAID E-147-2015-0-EP-14 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION EP DIV 20156778.1 Pending
NIAID E-086-2020-0-US-01 2019-nCoV VACCINE US 62/972,886 Abandoned
NCI E-053-2019-0-PCT-02 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES PCT PCT PCT/US2020/017515 Expired
NIAID E-131-2015-2-US-09 lNEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 16/786,267 Abandoned
NCI E-171-2018-9-US-05 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/786,013 Abandoned
NCI E-053-2019-0-CA-09 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES CA National Stage 3128871 Pending
NIAID E-032-2019-0-HK-08 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF HK EP 62022053678.8 Pending
NIAID E-032-2019-0-CN-04 Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform CN National Stage 202080013357.7 Pending